UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | H | J | K | L | M | N | O | P | R | S | T | U | V | W
Number of items: 78.

A

Ah-See, MW; Makris, A; Taylor, NJ; Harrison, M; Ostler, PJ; Richman, PI; ... Padhani, A; + view all (2004) Changes in dynamic contrast-enhanced MRI as an early predictor of response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 91 S22 - S22.

Ah-See, MW; Padhani, AR; Taylor, NJ; Daley, FM; Bentzen, SM; Burcombe, RJ; ... Makris, A; + view all (2004) Tumour microvasculature, assessment by dynamic contrast- enhanced MRI fails to correlate with VEGF expression in breast cancer biopsies. British Journal of Cancer , 91 S16 - S16.

Arkenau, HT; Porschen, R; (2004) Adjuvante chemotherapie des kurativ resezierten kolonkarzinoms. Verdauungskrankheiten , 22 (4) 208 - 215.

Arkenau, HT; Porschen, R; (2004) Adjuvante Therapie des kolorektalen Karzinoms. Verdauungskrankheiten 208 - 215.

B

BBC, NO; (2004) Drug boosts lung cancer survival. UNSPECIFIED

BBC, NORCR; (2004) 'They just didn't know what it would do'. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Passive smoking is a public health hazard. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Smart drug for lung cancer tested. UNSPECIFIED

Bentzen, SM; Bernier, J; Khalil, AA; Saunders, MI; Horiot, JC; Van den Bogaert, W; ... Dische, S; + view all (2004) Estimatet effect of patient non-compliance to dose-time constraints in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Strahlentherapie und Onkologie , 180 98 - 98.

Birtle, AJ; Newby, JC; Harland, SJ; (2004) Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer. British Journal of Cancer , 91 (8) 1472 - 1476.

Bouscary, D; Bardet, V; Sujobert, P; Cornillet-Lefebvre, P; Hayflick, JS; Prie, N; ... Lacombe, C; + view all (2004) Blockade of p110delta isoform activity of phosphoinositide 3-kinase inhibits blast cell proliferation in acute myeloblastic leukemia. In: BLOOD. (pp. 691A - 691A).

Bownes, P; Hoskin, PJ; Ostler, PJ; Lowe, GJ; Bryant, L; (2004) Quality assurance for fractionated high dose rate afterloading brachytherapy as monotherapy for prostate cancer. Radiotherapy and Oncology , 71 241 - ?.

Burroughs, A; Hochhauser, D; Meyer, T; (2004) Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol , 5 (7) 409 - 418. 10.1016/S1470-2045(04)01508-6.

C

Calvert, AH; (2004) Biochemical pharmacology of pemetrexed. Oncology (Williston Park) , 18 (13 Suppl 8) 13 - 17.

Cansick, JC; Lennon, R; Cummins, CL; Howie, AJ; McGraw, ME; Saleem, MA; ... Taylor, CM; + view all (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative)glomerulonephritis. Nephrology Dialysis Transplantation , 19 2769 - 2777.

Channel, 4IMF; (2004) Happy Birthday Thalidomide. UNSPECIFIED

Chester, JD; Hall, GD; Forster, M; Protheroe, AS; (2004) Systemic chemotherapy for patients with bladder cancer--current controversies and future directions. Cancer Treat Rev , 30 (4) 343 - 358. 10.1016/j.ctrv.2003.12.005.

Chester, K; Pedley, B; Tolner, B; Violet, J; Mayer, A; Sharma, S; ... Begent, R; + view all (2004) Engineering antibodies for clinical applications in cancer. Tumor Biology , 25 (1-2) 91 - 98.

Clamp, A; Adams, M; Atkinson, R; Boven, E; Calvert, AH; Cervantes, A; ... Jayson, GC; + view all (2004) A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-895 1f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer. GYNECOL ONCOL , 95 (1) 114 - 119. 10.1016/j.ygyno.2004.06.047.

Clingen, PH; Wu, J; Prise, KM; Hartley, JA; (2004) H2AX nuclear foci are induced in human cells after treatment with DNA interstrand crosslinking chemotherapeutics. BRITISH JOURNAL OF CANCER , 91 S48 - S48.

D

Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/Il dose-escalation trial evaluating the safety and tolerability of EP0906 plus capecitabine in patients with advanced cancer. Journal of Clinical Oncology , 22 (14) 2093 - ?.

F

Ffolkes, LV; Freeman, A; Harland, SJ; Parkinson, MC; (2004) Are there diagnostic problems with testis tumours? JOURNAL OF PATHOLOGY , 204 35A - 35A.

Forster, MD; Madhusudan, S; Muthuramalingam, SR; Braybrooke, JP; Wilner, S; Kaur, K; ... Harris, AL; + view all (2004) A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer. Clin Cancer Res. , 10 (19) 6528 - 6534.

H

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. Mutagenesis , 19 (6) 15 - ?.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. MUTAGENESIS , 19 (6) 504 - 504.

Hartley, JA; Spanswick, VJ; Brooks, N; Clingen, PH; McHugh, PJ; Hochhauser, D; ... Thurston, DE; + view all (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity. Cancer Res , 64 (18) 6693 - 6699. 10.1158/0008-5472.CAN-03-2941.

Helena Selby, BBCWSABBCR4; (2004) BBC World Service Health Matters Programme on Lung Cancer. UNSPECIFIED

Hoskin, PJ; (2004) Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against. Clinical Oncology , 16 (2) 112 - 114.

Howie, AJ; (2004) Defining the role of pathology services in the diagnosis and staging of renal cell carcinoma. In: Aitchison, M and Oliver, RTD and Miles, A, (eds.) The Effective Management of Renal Cell Carcinoma. (49 - 53). Aesculapius Medical Press: London.

Howie, AJ; Adu, D; (2004) Different meanings of 'glomerular tip lesion'. Kidney International , 66 1716 - ?.

Huhalov, A; Chester, KA; (2004) Engineered single chain antibody fragments for radioimmunotherapy. Q J Nucl Med Mol Imaging , 48 (4) 279 - 288.

Huhalov, A; Graff, C; Wittrup, KD; Tolner, B; Pedley, RB; Vervecken, W; ... Chester, KA; + view all (2004) HSAbodies: A new class of engineered antibody-based molecules for targeting cancer. BRITISH JOURNAL OF CANCER , 91 S63 - S63.

Huhalov, A; Spencer, DIR; Chester, KA; (2004) A strategy for characterizing antibody/antigen interactions using proteinchip arrays. In: Conn, PM, (ed.) Handbook of proteomic methods. (117 - 128). Humana Press: New Jersey.

J

Jia, L; Spanswick, VJ; Reid, JM; Kuffel, M; Buhrow, SA; Ames, MM; ... Tomaszewski, JE; + view all (2004) Use of the comet assay as a surrogate biomarker for the in vivo measurement of DNA damage to lymphocytes. Proceedings of the American Association for Cancer Research , 45 1969 - ?.

K

Kakkar, AK; Bundred, N; Carpenter, R; Makris, A; Merriman, H; Walker, ID; (2004) Venous thromboembolism in cancer patients. Guidelines. EGUIDELINES , 23 311 - 314.

Kiakos, K; Hartley, JA; Price, C; Lingerfelt, B; Handl, H; Lee, M; (2004) Design, synthesis and DNA alkylation specificity of novel achiral seco-CI-polyamide hairpin conjugates. Proceedings of the American Association for Cancer Research , 45 3091 - ?.

Kiakos, K; Mchugh, PJ; Hartley, JA; Sato, K; Summerville, K; C, L; M,; (2004) Design, synthesis and biological evaluation of AS-I-145, a novel achiral amino seco-CBI. Proceedings of the American Association for Cancer Research , 45 3998 - ?.

Kristeleit, RS; Stimson, L; Workman, P; Aherne, G; (2004) Histone modification enzymes: novel targets for cancer drugs. Expert Opinion on Emerging Drugs , 9 (1)

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; ... Lee, M; + view all (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. Bioorganic and Medicinal Chemistry , 12 (23) 6221 - 6236.

L

Lankester, KJ; Maxwell, RJ; Pedley, RB; Hill, SA; Rustin, GJS; Tozer, GM; (2004) Acute anti-vascular effects of combretastatin A4 phosphate (CA-4-P) on the SW1222 tumour as measured by dynamic contrast enhanced (DCE)-MRI. BRITISH JOURNAL OF CANCER , 91 S16 - S16.

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. Mutagenesis , 19 (6) 51 - ?.

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. MUTAGENESIS , 19 (6) 516 - 516.

Litchfield, TM; Gilchrist, S; Sunderland, R; Folkard, M; Short, S; Prise, K; (2004) A three dimensional tissue culture model for microbeam studies. In: Proc Society for neuroscience 34th annual meeting, San Diego. (pp. P 462.4 - ?).

Liu, WM; Strauss, SJ; Chaplin, T; Shahin, S; Propper, DJ; Young, BD; ... Malpas, JS; + view all (2004) s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line. Hematol J , 5 , Article 3.

M

Makris, A; (2004) Critical commentary of: HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. Women's Oncology Review , 4 277 - 278.

Makris, A; (2004) Critical commentary of: Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. Women's Oncology Review , 4 213 - 214.

Makris, A; Glynne-Jones, R; Sebag-Montefiore, D; Samuel, L; Myint, S; Levine, E; ... Dixon, J; + view all (2004) Compliance to chemotherapy with oxaliplatin and 5fluorouracil in patients with advanced rectal cancer who rave received prior high-dose pelvic radiotherapy. British Journal of Cancer , 91 S34 - S34.

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; ... Begent, RHJ; + view all (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. British Journal of Cancer , 91 S8 - S8.

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; ... Begent, RHJ; + view all (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. In: BRITISH JOURNAL OF CANCER. (pp. S8 - S8). NATURE PUBLISHING GROUP

McGurk, CJ; Cummings, M; Hartley, JA; Masters, JR; (2004) Translational regulation of ERCC1 in human cancer cell lines. Proceedings of the American Association for Cancer Research , 45 2631 - ?.

Mchugh, PJ; Hartley, JA; (2004) Repair of DNA interstrand crosslinks Produced by Cancer Chemotherapeutic Drugs. In: Panasci, LC and Alaoui-Jamali, MA, (eds.) DNA Repair in Cancer Therapy. (31 - 49). Humana Press: Totowa. NJ.

McMeish, I; Kanfer, EJ; Haynes, R; Giles, C; Harland, SJ; Driver, D; ... Seckl, MJ; + view all (2004) Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. British Journal of Cancer , 90 (6) 1169 - 1175.

N

Novak-Hofer, I; Waibel, R; Zimmermann, K; Schibli, R; Grünberg,; J,; ... P, A; + view all (2004) Radiometal labeling of antibodies and antibody fragments for imaging and therapy. In: Methods Mol Biol. (481 - 494). Humana Press

O

O'Donnell, A; Judson, I; Dowsett, M; Raynaud, F; Dearnaley, D; Mason, M; ... Jarman, M; + view all (2004) Hormonal impact of the 17 alpha-hydroxylase/C-17,C-20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. British Journal of Cancer , 90 (12) 2317 - 2325.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. Circulation Research , 95 (4) 380 - 388.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. Biochem Soc Trans , 32 (Pt 2) 332 - 335.

P

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (491 - 514).

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed Enzyme Prodrug Therapy. In: Springer, CJ, (ed.) Suicide Gene Therapy: Methods and Protocols for Cancer. (491 - 514). Humana Press: Totowa, New Yersey.

R

Reif, K; Okkenhaug, K; Sasaki, T; Penninger, JM; Vanhaesebroeck, B; Cyster, JG; (2004) Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol , 173 (4) 2236 - 2240.

S

Short, S; (2004) UNSPECIFIED In: (Proceedings) ESTRO 23, Amsterdam.

Short, SM; Makris, A; Jones, RG; Novell, R; Harrison, M; (2004) Low dose continuous hyperfractionated accelerated radiation therapy (CHART) as preoperative treatment for rectal carcinoma. British Journal of Cancer , 91 S38 - S38.

Sibtain, A; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2004) Pre-treatment haemoglobin concentration in accelerated and conventional radiotherapy for non-small cell lung carcinoma. Clinical Oncology , 16 (1) 58 - 62.

Sky, NRJJ; (2004) Cost issues behind government health reforms. UNSPECIFIED

Stewart, G; Lee, SM; (2004) Poor performance status patients and the TOPICAL Trial. Lung Cancer in Practice , 1 (3) 1 - 3.

Stewart, M; Daniell, K; Madsen, E; Le, M; Handl, H; Brooks, N; ... Lee, M; + view all (2004) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral analogs of duocarmycin SA. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U29 - U29). AMER CHEMICAL SOC

Stewart, M; Daniell, K; Madsen, E; Le, M; Handl, H; Brooks, N; ... Lee, M; + view all (2004) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral analogs of duocarmycin SA. In: Abstracts of Papers of the American Chemical Society. (pp. U29 - U29).

Strauss, SJ; McTiernan, A; Whelan, JS; (2004) Late relapse of osteosarcoma: Implications for follow-up and screening. Pediatric Blood and Cancer , 43 (6) 692 - 697. 10.1002/pbc.20154.

T

T M Litchfield, G; S, S; R, F; M, S; S, P; K,; (2004) UNSPECIFIED In: (Proceedings) Society for Neuroscience 34th Annual Meeting.

Taylor, CM; Chua, C; Howie, AJ; Risdon, RA; (2004) Clinico-pathological findings in haemolytic uraemic syndrome not associated with diarrhoea. Pediatric Nephrology , 19 419 - 425.

Twelves, C; Gokul, S; Jones, RH; Boddy, A; Macham, M; Fishwick, K; ... Calvert, AH; + view all (2004) Phase I study to evaluate the safety, tolerability and pharmacokinetics of OSI-211 (Liposomal Lurtotecan) in combination with Carboplatin. ANN ONCOL , 15 105 - 105.

U

Urbaniak, MD; Bingham, JP; Hartley, JA; Woolfson, DN; Caddick, S; (2004) Improved Stability of Nitrogen-Mustard Derivatives Using apo-Neocarzinostatin. Journal of Medicinal Chemistry , 47 4710 - 4715.

V

Van Zuylen, L; Sparreboom, A; Eskens, FALM; De Bruijn, P; Planting, AST; Verweij, J; ... Mueller, C; + view all (2004) Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/Leucovorin in Metastatic Colorectal Cancer. Clinical Cancer Research , 10 (6) 1949 - 1955. 10.1158/1078-0432.CCR-02-0995.

Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: attention to detail. Cell , 118 (3) 375 - 387.

Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: attention to detail. Cell , 118 (3) 274 - 276. 10.1016/j.cell.2004.07.018.

W

Whelan, J; (2004) Late Effects of Childhood Cancer. Lancet Oncology

Whelan, JS; McTiernan, A; (2004) for the London Bone and Soft Tissue Tumour Service. A prospective study of pre-operative chemotherapy with single agent ifosfamide for malignant fibrous histiocytoma of bone. Sarcoma , 8 77 - 82. Gold open access

Whelan, JS; McTiernan, AM; Strauss, SJ; (2004) Single centre experience of a new intensive induction therapy for Ewing’s family of tumours using Holoxan in the VIDE regimen. Final results and conclusions. In: International Society of Paediatric Oncology SIOP XXXV Meeting, Oslo, Norway, September 2004.

Whelan, JS; Morland, B; (2004) Bone Tumours. In: Pinkerton, CR and Plowman, P, (eds.) Paediatric Oncology. Clinical Practice and Controversies. : London.

This list was generated on Wed Jan 21 20:49:46 2015 GMT.